Australia markets closed

SAVA Jan 2025 20.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.2200+0.6700 (+18.87%)
At close: 03:58PM EDT
Full screen
Previous close3.5500
Open4.0000
Bid3.1500
Ask4.4500
Strike20.00
Expiry date2025-01-17
Day's range4.0000 - 4.3000
Contract rangeN/A
Volume6
Open interest1.6k
  • Zacks

    Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

    Cassava Sciences, Inc. (SAVA) and Lexeo Therapeutics (LXEO) are in the spotlight following updates.

  • GlobeNewswire

    Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

    Rick Barry appointed Executive Chairman of the BoardRemi Barbier resigns as President and CEO and from the Board of DirectorsCassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Board of Directors has appointed Richard (Rick) Barry as Executive Chairman of the Board and as the Company’s principal executive officer, effective immediately. The Company is undertaking a search for a new permanent CEO. M

  • Yahoo Finance Video

    Cassava forms committee after US probe, researcher fraud

    Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.